Legal Opinion
University of Utah v. Max-Planck-Gesellschaft Zur Föerderung Der Wissenschaften e.V.
District Court, D. Massachusetts
Decided September 28, 2015No. Civil Action No. 11-10484-PBSPublishedCited by 3 opinions
1Opinion of the Court
MEMORANDUM AND ORDER
Patti B. Saris, Chief United States District Judge
INTRODUCTION
This case concerns the field of RNA interference (RNAi), which is a process for inhibiting gene expression also known as “gene silencing.” RNAi plays an important role in defending cells against viruses and other diseases.1 In 2011, plaintiff University of Utah (UUtah) brought this action against Max-Planck-Gesellschaft Zur Foer-derung Der Wissenschaften e.V. (Max Planck), the Whitehead Institute for Biomedical Research (Whitehead), the Massachusetts Institute of Technology (MIT), Alnylam Pharmaceuticals, Inc.…
2Cases cited17 opinions
- Association for Molecular Pathology v. Myriad Genetics, Inc.Supreme Court of the United States · 2013
- Ethicon, Inc. And Inbae Yoon, M.D. v. United States Surgical Corporation and Young Jae ChoiCourt of Appeals for the Federal Circuit · 1998
- Burroughs Wellcome Co. v. Barr Laboratories, Inc., and Novopharm, Inc. And Novopharm, Ltd.Court of Appeals for the Federal Circuit · 1994
- Eli Lilly and Company v. Aradigm Corporation, Defendant-CrossCourt of Appeals for the Federal Circuit · 2004
- Fina Oil and Chemical Co. And Fina Technology, Inc. v. John A. Ewen v. Abbas Razavi, Intervenor-AppelleeCourt of Appeals for the Federal Circuit · 1997
12 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Maxtech Consumer Products, Ltd. v. Robert Bosch Tool Corp.District Court, N.D. Illinois · 2017
- Dana-Farber Cancer Inst., Inc. v. Ono Pharm. Co.District Court, District of Columbia · 2019
- Edwards Lifesciences CardiAQ, LLC v. Kenneth PerryDistrict Court, D. Massachusetts · 2019